A Miranda-Filho, J Lortet-Tieulent, F Bray, B Cao, S Franceschi, S Vaccarella, et al., Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 9(4), 225–234 (2021).

Article  PubMed  Google Scholar 

C Christofer Juhlin, O Mete, Z.W Baloch, The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr. Relat. Cancer 30(2), e220293 (2023).

Article  CAS  PubMed  Google Scholar 

I.D Hay, G.B Thompson, C.S Grant, E.J Bergstralh, C.E Dvorak, C.A Gorman, et al., Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J. Surg. 26(8), 879–885 (2002).

Article  PubMed  Google Scholar 

B.R Haugen, E.K Alexander, K.C Bible, G.M Doherty, S.J Mandel, Y.E Nikiforov, et al., 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016).

Article  PubMed  PubMed Central  Google Scholar 

R.I Haddad, C Nasr, L Bischoff, N.L Busaidy, D Byrd, G Callender, et al., NCCN guidelines insights: thyroid carcinoma, version 2.2018. J. Natl Compr. Canc Netw. 16(12), 1429–1440 (2018).

Article  PubMed  Google Scholar 

M.N Nikiforova, A.I Wald, S Roy, M.B Durso, Y.E Nikiforov, Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J. Clin. Endocrinol. Metab. 98(11), E1852–E1860 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y.Y Cho, S.Y Park, J.H Shin, Y.L Oh, J.H Choe, J.H Kim, et al., Highly sensitive and specific molecular test for mutations in the diagnosis of thyroid nodules: a prospective study of BRAF-prevalent population. Int. J. Mol. Sci. 21(16), 5629 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

L Jianyong, Z Jinjing, L Zhihui, W Tao, G Rixiang, Z Jingqiang, A nomogram based on the characteristics of metastatic lymph nodes to predict papillary thyroid carcinoma recurrence. Thyroid 28(3), 301–310 (2018).

Article  PubMed  Google Scholar 

A Subash, P Sinha, A Singh, BRAF mutation and age in differentiated thyroid cancer risk stratification: two sides of the same coin. Oral. Oncol. 106, 104732 (2020).

Article  CAS  PubMed  Google Scholar 

Y Chen, P.M Sadow, H Suh, K.E Lee, J.Y Choi, Y.J Suh, et al., BRAF(V600E) is correlated with recurrence of papillary thyroid microcarcinoma: a systematic review, multi-institutional primary data analysis, and meta-analysis. Thyroid 26(2), 248–255 (2016).

Article  CAS  PubMed  Google Scholar 

M Xing, A.S Alzahrani, K.A Carson, Y.K Shong, T.Y Kim, D Viola, et al., Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J. Clin. Oncol. 33(1), 42–50 (2015).

Article  PubMed  Google Scholar 

M Yarchoan, V.A LiVolsi, M.S Brose, BRAF mutation and thyroid cancer recurrence. J. Clin. Oncol. 33(1), 7–8 (2015).

Article  PubMed  Google Scholar 

C Bal, S Ballal, Is there any true association between BRAF V600E mutation and recurrence, particularly in low-risk, papillary thyroid cancer? J. Clin. Oncol. 33(22), 2481 (2015).

Article  CAS  PubMed  Google Scholar 

C Geng, S Tian, X Gao, X Li, Q Ru, P Zhang, Establishment and validation of a nomogram to predict structural incomplete response in papillary thyroid carcinoma patients: a retrospective study. J. Int. Med. Res. 51(1), 3000605221149880 (2023).

Article  CAS  PubMed  Google Scholar 

H.R Won, M.G Kim, M.S Kim, J.W Chang, B.S Koo, Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence. Eur. Thyroid. J. 12(6), e230195 (2023).

Article  PubMed  PubMed Central  Google Scholar 

L Lamartina, G Grani, E Arvat, A Nervo, M.C Zatelli, R Rossi, et al., 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocr. Relat. Cancer 25(3), L7–L11 (2018).

Article  PubMed  Google Scholar 

P Guo, X Wang, L Xia, N Shawureding, Z Hu, Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model. Cancer Med. 12(7), 7868–7876 (2023).

Article  CAS  PubMed  Google Scholar 

M.D Bortz, K Kuchta, D.J Winchester, R.A Prinz, T.A Moo-Young, Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer. Surgery 169(1), 2–6 (2021).

Article  PubMed  Google Scholar 

W.R. Choi, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi, S.Y. Nam et al. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence. Oral. Oncol. 94, 106–110 (2019)

Article  PubMed  Google Scholar 

T.H. Zhou, B. Lin, F. Wu, K.N. Lu, L.L. Mao, L.Q. Zhao et al. Extranodal extension is an independent prognostic factor in papillary thyroid cancer: a propensity score matching analysis. Front. Endocrinol. 12, 759049 (2021)

Article  Google Scholar 

L Yip, M.N Nikiforova, J.Y Yoo, K.L McCoy, M.T Stang, M.J Armstrong, et al., Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients. Ann. Surg. 262(3), 519–525 (2015).

Article  PubMed  Google Scholar 

K.W Chung, M.C Chang, D.Y Noh, S.K Oh, K.J Choe, Y.K Youn, RET oncogene expression of papillary thyroid carcinoma in Korea. Surg. Today 34(6), 485–492 (2004).

Article  CAS  PubMed  Google Scholar 

D Pamedytyte, V Simanaviciene, D Dauksiene, E Leipute, A Zvirbliene, V Sarauskas, et al., Association of MicroRNA expression and BRAF(V600E) mutation with recurrence of thyroid cancer. Biomolecules 10(4), 625 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

P Li, Y Liu, T Wei, X Wang, J Zhu, R Yang, et al., Effect and interactions of BRAF on lymph node metastasis in papillary thyroid carcinoma with hashimoto thyroiditis. J. Clin. Endocrinol. Metab. 109(4), 944–954 (2024).

Article  PubMed  Google Scholar 

H Cai, L Zhuge, Z Huang, S Wang, P Shi, D Yan, et al., Distinct risk factors of lateral lymph node metastasis in patients with papillary thyroid cancer based on age stratification. BMC Surg. 24(1), 24 (2024).

Article  PubMed  PubMed Central  Google Scholar 

W.X Wu, G.F Qi, J.W Feng, J Ye, L.Z Hong, F Wang, et al., Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification. Eur. Arch. Otorhinolaryngol. 280(5), 2511–2523 (2023).

Article  PubMed  Google Scholar 

M.P Pusztaszeri, J.F Krane, W.C Faquin, BRAF testing and thyroid FNA. Cancer Cytopathol. 123(12), 689–695 (2015).

Article  PubMed  Google Scholar 

D.N Poller, S Glaysher, A Agrawal, S Caldera, D Kim, C Yiangou, BRAF V600 co-testing in thyroid FNA cytology: short-term experience in a large cancer centre in the UK. J. Clin. Pathol. 67(8), 684–689 (2014).

Article  PubMed  Google Scholar